new glp-1 agonists England Journalist of Medicine published great article. Read it to learn more about the science behind medications. GLP-1 receptor are increasingly used to treat type 2 diabetes and obesity GLP-1 receptor agonists | How

Clinical trials demonstrated 13.7 percent average body weight loss at 72 weeks, with many participants exceeding 15 percent

While most people taking GLP-1s deal with daily discomfort rather than emergencies, Carroll says that there are some serious complications worth knowing about, including acute pancreatitis, gallbladder disease, and severe dehydration from prolonged vomiting or diarrhea

Hepatology 75 (6), 15231538

The number of adults diagnosed with diabetes has almost quadrupled since 1980, rising from 108 million to 422 million in 2014, according to the World Health Organization

All content is framed for research use only no clinical or therapeutic claims are made